NYSE : USNA
USANA Health Sciences, Inc. — Key statistics
Consumer Staples · Packaged Foods · United States
Last price 14.34 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 264.95M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 264.40M |
| Enterprise Value | 95.84M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 18.48M |
| Shares Outstanding | 18.48M |
| Shares Change (YoY) | -3.10% |
| Shares Change (QoQ) | +0.41% |
| Owned by Insiders (%) | 41.01% |
| Owned by Institutions (%) | 56.99% |
| Float | 9.92M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 14.03 |
| PS Ratio | 0.29 |
| Forward PS | 0.29 |
| PB Ratio | 0.50 |
| P/TBV Ratio | 0.90 |
| P/FCF Ratio | 16.59 |
| P/OCF Ratio | 9.54 |
| PEG Ratio | 1.17 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.10 |
| EV / EBITDA | 1.30 |
| EV / EBIT | 2.31 |
| EV / FCF | 6.01 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.66 |
| Quick Ratio | 1.63 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 100.70 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -5.06% |
| Return on Assets (ROA) | 3.61% |
| Return on Invested Capital (ROIC) | -112.80% |
| Return on Capital Employed (ROCE) | 6.94% |
| Weighted Average Cost of Capital (WACC) | 8.00% |
| Revenue Per Employee | $581,759 |
| Profits Per Employee | -$14,117 |
| Employee Count | 1,570 |
| Asset Turnover | 1.27 |
| Inventory Turnover | 2.43 |
Taxes
| Measure | Value |
|---|
| Income Tax | 31.79M |
| Effective Tax Rate | 1,253.35% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.68 |
| 52-Week Price Change | -27.03% |
| 50-Day Moving Average | 14.55 |
| 200-Day Moving Average | 18.11 |
| Relative Strength Index (RSI) | 45.29 |
| Average Volume (20 Days) | 177,474 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 779,033 |
| Short Previous Month | 754,694 |
| Short % of Shares Out | 4.22% |
| Short % of Float | 7.85% |
| Short Ratio (days to cover) | 4.28 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 913.36M |
| Gross Profit | 707.36M |
| Operating Income | 41.49M |
| Pretax Income | 2.54M |
| Net Income | -22.16M |
| EBITDA | 73.92M |
| EBIT | 41.49M |
| Loss Per Share | -$1.21 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 168.56M |
| Total Debt | n/a |
| Net Cash | 168.56M |
| Net Cash Per Share | $9.12 |
| Equity (Book Value) | 570.97M |
| Book Value Per Share | 28.51 |
| Working Capital | 175.39M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 27.73M |
| Capital Expenditures | -11.79M |
| Depreciation & Amortization | 32.43M |
| Net Borrowing | n/a |
| Free Cash Flow | 15.93M |
| FCF Per Share | $0.86 |
Margins
| Measure | Value |
|---|
| Gross Margin | 77.45% |
| Operating Margin | 4.54% |
| Pretax Margin | 0.28% |
| Profit Margin | -2.43% |
| EBITDA Margin | 8.09% |
| EBIT Margin | 4.54% |
| FCF Margin | 1.74% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 3.10% |
| Shareholder Yield | 3.10% |
| Earnings Yield | -8.43% |
| FCF Yield | 6.03% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Nov 23, 2016 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 4.58 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |